Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunogenic cell stress and death
Guido Kroemer, Claudia Galassi, Laurence Zitvogel, et al.
Nature Immunology (2022) Vol. 23, Iss. 4, pp. 487-500
Open Access | Times Cited: 754

Showing 1-25 of 754 citing articles:

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
Karin E. de Visser, Johanna A. Joyce
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 374-403
Open Access | Times Cited: 1233
Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
Weitong Gao, Yuqin Wang, Yang Zhou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 513
Mitochondrial control of inflammation
Saverio Marchi, Emma Guilbaud, Stephen W. G. Tait, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 159-173
Open Access | Times Cited: 475
Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency
Zhilin Li, Xiaoqin Lai, Shiqin Fu, et al.
Advanced Science (2022) Vol. 9, Iss. 22
Open Access | Times Cited: 327
Antibody–drug conjugates come of age in oncology
Charles Dumontet, Janice M. Reichert, Peter D. Senter, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 8, pp. 641-661
Closed Access | Times Cited: 298
Meta-hallmarks of aging and cancer
Carlos López‐Otín, Federico Pietrocola, David Roiz‐Valle, et al.
Cell Metabolism (2023) Vol. 35, Iss. 1, pp. 12-35
Open Access | Times Cited: 231
Pathogenesis of autoimmune disease
David S. Pisetsky
Nature Reviews Nephrology (2023) Vol. 19, Iss. 8, pp. 509-524
Open Access | Times Cited: 228
Cellular Senescence Is Immunogenic and Promotes Antitumor Immunity
Inés Marín, Olga Boix, Andrea García-Garijo, et al.
Cancer Discovery (2022) Vol. 13, Iss. 2, pp. 410-431
Open Access | Times Cited: 170
Emerging evidence for adapting radiotherapy to immunotherapy
Lorenzo Galluzzi, Molykutty J. Aryankalayil, C. Norman Coleman, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 543-557
Closed Access | Times Cited: 138
Chronic inflammation and the hallmarks of aging
Jordan J. Baechle, Nan Chen, Priya Makhijani, et al.
Molecular Metabolism (2023) Vol. 74, pp. 101755-101755
Open Access | Times Cited: 121
Emerging Sonodynamic Therapy‐Based Nanomedicines for Cancer Immunotherapy
Yunrong Yang, Jia Huang, Min Liu, et al.
Advanced Science (2022) Vol. 10, Iss. 2
Open Access | Times Cited: 120
A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody
Zhilin Li, Hao Cai, Zhiqian Li, et al.
Bioactive Materials (2022) Vol. 21, pp. 299-312
Open Access | Times Cited: 115
Bioactive inorganic nanomaterials for cancer theranostics
Zifan Pei, Huali Lei, Liang Cheng
Chemical Society Reviews (2023) Vol. 52, Iss. 6, pp. 2031-2081
Closed Access | Times Cited: 108
Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies
Qian Zhou, Yu Meng, Daishi Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 91
Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
Raquel S. Laureano, Jenny Sprooten, Isaure Vanmeerbeerk, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 84
NK cells and solid tumors: therapeutic potential and persisting obstacles
Le Tong, Carlos Jiménez‐Cortegana, Apple H.M. Tay, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 84
Metal-organic framework nanoagent induces cuproptosis for effective immunotherapy of malignant glioblastoma
Qian‐Xiao Huang, Jun‐Long Liang, Qi‐Wen Chen, et al.
Nano Today (2023) Vol. 51, pp. 101911-101911
Closed Access | Times Cited: 84
Covalent organic framework nanomedicines: Biocompatibility for advanced nanocarriers and cancer theranostics applications
Nem Singh, Jungryun Kim, Jaewon Kim, et al.
Bioactive Materials (2022) Vol. 21, pp. 358-380
Open Access | Times Cited: 77
At the crossroads of immunotherapy for oncogene-addicted subsets of NSCLC
Itziar Otano, Álvaro C. Ucero, Jon Zugazagoitia, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 3, pp. 143-159
Closed Access | Times Cited: 73
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B
Martina Musella, Andrea Guarracino, Nicoletta Manduca, et al.
Nature Immunology (2022) Vol. 23, Iss. 9, pp. 1379-1392
Open Access | Times Cited: 72
Tumor Microenvironment-Activable Manganese-Boosted Catalytic Immunotherapy Combined with PD-1 Checkpoint Blockade
Zhiyu Zhao, Shuming Dong, Yue Liu, et al.
ACS Nano (2022) Vol. 16, Iss. 12, pp. 20400-20418
Closed Access | Times Cited: 72
Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer
J. Li, Jiao Liu, Zhuan Zhou, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 720
Closed Access | Times Cited: 72
Immunogenic cell death in cancer: concept and therapeutic implications
Lorenzo Galluzzi, Oliver Kepp, Erik C. Hett, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 67
Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T cell responses
Jay K. Mandula, Shiun Chang, Eslam Mohamed, et al.
Cancer Cell (2022) Vol. 40, Iss. 10, pp. 1145-1160.e9
Open Access | Times Cited: 64
Immuno-photodynamic Therapy (IPDT): Organic Photosensitizers and Their Application in Cancer Ablation
Lu Yang, Wen Sun, Jianjun Du, et al.
JACS Au (2023) Vol. 3, Iss. 3, pp. 682-699
Open Access | Times Cited: 56
Page 1 - Next Page

Scroll to top